01-08-2005
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)
Published in: Investigational New Drugs | Issue 4/2005
Login to get access